Finepoint Capital LP 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Finepoint Capital LP disclosed 8 US equity positions worth $504.3m in its Q2 2025 13F filing. The largest position was QXO at 90.4% of the reported book, followed by LIBERTY MEDIA CORP DEL and SLDB. Against the Q1 2025 filing, it opened 0 new positions, added to 1 and reduced 1 among the top 8 holdings.
What did Finepoint Capital LP own in Q2 2025? Top 8 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | QXO QXO INC | Industrials | 90.4% | $455.6m | 21,152,868 | -14% | reduced |
| 2 | LIBERTY MEDIA CORP DEL | 8.6% | $43.6m | 537,051 | 24% | added | |
| 3 | SLDB SOLID BIOSCIENCES INC | Healthcare | 0.9% | $4.7m | 961,251 | 0% | held |
| 4 | ALEANNA INC | 0.0% | $199.6k | 27,717 | 0% | held | |
| 5 | ALEANNA INC | 0.0% | $115.2k | 490,000 | 0% | held | |
| 6 | MONEYHERO LTD | 0.0% | $41.9k | 895,000 | 0% | held | |
| 7 | LAKESHORE BIOPHARMA CO LTD | 0.0% | $19.6k | 489,999 | 0% | held | |
| 8 | CALIDI BIOTHERAPEUTICS INC | 0.0% | $2.9k | 12,499 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.